Lægemiddelindustriforeningen - Side 1

Date: 23 February 2010 Lif's ethical rules for pharmaceutical companies' relations with the Danish hospital sector Preamble Good relations between the Danish hospitals and the pharmaceutical companies are crucial for the conduct of clinical trials, setting up quality assurance studies, disseminating information on new drugs and their use and other activities aimed at supporting better treatment for patients. In order to ensure a good professional basis for relations between the pharmaceutical industry and the Danish hospitals, there must be no doubts as to the exchange of knowledge and dialogue between the parties that is essential for continuing development of new drugs that improve the treatment of patients. Collaboration on clinical research is essential for the researching pharmaceutical industry to bring new innovative drugs to market. The use of drugs in day-to-day clinical routines, prior education and training activities for the use of certain new drugs and ongoing monitoring of the effects of the drugs concerned are situations that require close collaboration between the pharmaceutical companies and the Danish hospitals. Communication activities by the pharmaceutical companies are aimed at ensuring that health professionals have easy, flexible access to information on drugs and their use so that drugs are used appropriately for the benefit of patients. The pharmaceutical companies therefore have an obligation and a responsibility to produce precise information on their drugs and their use. Purpose This set of ethical rules is aimed at ensuring high ethical standards for contacts by the pharmaceutical companies with the Danish hospitals associated with information on drugs. These rules are aimed at activities associated with product information and training /instruction. These rules accordingly supplement the various agreements on clinical trials, non-intervention trials, etc., that currently regulate relations between the pharmaceutical companies and health professionals.

Side 2